Clinical Utility of Emerging Molecular Diagnostics in Breast Cancer
March 9th 2016The past decade of biomarker research has led to the introduction of several multigene prognostic tests that are now routinely used in clinical decision making to assist the se-lection of patients for adjuvant chemotherapy, and several other tests have emerged with potential clinical utility.
Read More